Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
Identifieur interne : 001A75 ( PubMed/Checkpoint ); précédent : 001A74; suivant : 001A76Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
Auteurs : Khaled M. Abd Elaziz [Égypte] ; Maged El-Setouhy ; Mark H. Bradley ; Reda M R. Ramzy ; Gary J. WeilSource :
- The American journal of tropical medicine and hygiene [ 1476-1645 ] ; 2013.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Albendazole (administration et posologie), Albendazole (usage thérapeutique), Animaux, Connaissances, attitudes et pratiques en santé, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Enquêtes et questionnaires, Facteurs sexuels, Femelle, Filaricides (administration et posologie), Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (psychologie), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Insecticides, Jeune adulte, Lutte contre les moustiques (), Moustiquaires de lit traitées aux insecticides, Mâle, Observance du traitement médicamenteux (psychologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Wuchereria bancrofti, Égypte (épidémiologie).
- MESH :
- administration et posologie : Albendazole, Diéthylcarbamazine, Filaricides.
- psychologie : Filariose lymphatique, Observance du traitement médicamenteux.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Diéthylcarbamazine, Filaricides.
- épidémiologie : Filariose lymphatique, Égypte.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Connaissances, attitudes et pratiques en santé, Enquêtes et questionnaires, Facteurs sexuels, Femelle, Filariose lymphatique, Humains, Insecticides, Jeune adulte, Lutte contre les moustiques, Moustiquaires de lit traitées aux insecticides, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Wuchereria bancrofti.
- Wicri :
- geographic : Égypte.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Albendazole (administration & dosage), Albendazole (therapeutic use), Animals, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Egypt (epidemiology), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Elephantiasis, Filarial (psychology), Female, Filaricides (administration & dosage), Filaricides (therapeutic use), Health Knowledge, Attitudes, Practice, Humans, Insecticide-Treated Bednets, Insecticides, Male, Medication Adherence (psychology), Middle Aged, Mosquito Control (methods), Sex Factors, Surveys and Questionnaires, Wuchereria bancrofti, Young Adult.
- MESH :
- chemical , administration & dosage : Albendazole, Diethylcarbamazine, Filaricides.
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides.
- geographic , epidemiology : Egypt.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- methods : Mosquito Control.
- prevention & control : Elephantiasis, Filarial.
- psychology : Elephantiasis, Filarial, Medication Adherence.
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Female, Health Knowledge, Attitudes, Practice, Humans, Insecticide-Treated Bednets, Insecticides, Male, Middle Aged, Sex Factors, Surveys and Questionnaires, Wuchereria bancrofti, Young Adult.
Abstract
Lymphatic filariasis (LF) has been targeted for global elimination by 2020. The primary tool for the program is mass drug administration (MDA) with antifilarial medications to reduce the source of microfilariae required for mosquito transmission of the parasite. This strategy requires high MDA compliance rates. Egypt initiated a national filariasis elimination program in 2000 that targeted approximately 2.7 million persons in 181 disease-endemic localities. This study assessed factors associated with MDA compliance in year three of the Egyptian LF elimination program. 2,859 subjects were interviewed in six villages. The surveyed compliance rate for MDA in these villages was 85.3% (95% confidence interval = 83.9-86.5%). Compliance with MDA was positively associated with LF knowledge scores, male sex, and older age. Adverse events reported by 18.4% of participants were mild and more common in females. This study has provided new information on factors associated with MDA compliance during Egypt's successful LF elimination program.
DOI: 10.4269/ajtmh.12-0491
PubMed: 23751402
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23751402Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.</title><author><name sortKey="Abd Elaziz, Khaled M" sort="Abd Elaziz, Khaled M" uniqKey="Abd Elaziz K" first="Khaled M" last="Abd Elaziz">Khaled M. Abd Elaziz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, and Research and Training Center on Vector of Diseases Ain Shams University, Cairo, Egypt. khaledabdu@yahoo.com</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, and Research and Training Center on Vector of Diseases Ain Shams University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="El Setouhy, Maged" sort="El Setouhy, Maged" uniqKey="El Setouhy M" first="Maged" last="El-Setouhy">Maged El-Setouhy</name></author><author><name sortKey="Bradley, Mark H" sort="Bradley, Mark H" uniqKey="Bradley M" first="Mark H" last="Bradley">Mark H. Bradley</name></author><author><name sortKey="Ramzy, Reda M R" sort="Ramzy, Reda M R" uniqKey="Ramzy R" first="Reda M R" last="Ramzy">Reda M R. Ramzy</name></author><author><name sortKey="Weil, Gary J" sort="Weil, Gary J" uniqKey="Weil G" first="Gary J" last="Weil">Gary J. Weil</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23751402</idno><idno type="pmid">23751402</idno><idno type="doi">10.4269/ajtmh.12-0491</idno><idno type="wicri:Area/PubMed/Corpus">001A91</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A91</idno><idno type="wicri:Area/PubMed/Curation">001A91</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A91</idno><idno type="wicri:Area/PubMed/Checkpoint">001A91</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A91</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.</title><author><name sortKey="Abd Elaziz, Khaled M" sort="Abd Elaziz, Khaled M" uniqKey="Abd Elaziz K" first="Khaled M" last="Abd Elaziz">Khaled M. Abd Elaziz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, and Research and Training Center on Vector of Diseases Ain Shams University, Cairo, Egypt. khaledabdu@yahoo.com</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, and Research and Training Center on Vector of Diseases Ain Shams University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="El Setouhy, Maged" sort="El Setouhy, Maged" uniqKey="El Setouhy M" first="Maged" last="El-Setouhy">Maged El-Setouhy</name></author><author><name sortKey="Bradley, Mark H" sort="Bradley, Mark H" uniqKey="Bradley M" first="Mark H" last="Bradley">Mark H. Bradley</name></author><author><name sortKey="Ramzy, Reda M R" sort="Ramzy, Reda M R" uniqKey="Ramzy R" first="Reda M R" last="Ramzy">Reda M R. Ramzy</name></author><author><name sortKey="Weil, Gary J" sort="Weil, Gary J" uniqKey="Weil G" first="Gary J" last="Weil">Gary J. Weil</name></author></analytic><series><title level="j">The American journal of tropical medicine and hygiene</title><idno type="eISSN">1476-1645</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Albendazole (administration & dosage)</term><term>Albendazole (therapeutic use)</term><term>Animals</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Egypt (epidemiology)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Elephantiasis, Filarial (psychology)</term><term>Female</term><term>Filaricides (administration & dosage)</term><term>Filaricides (therapeutic use)</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Insecticide-Treated Bednets</term><term>Insecticides</term><term>Male</term><term>Medication Adherence (psychology)</term><term>Middle Aged</term><term>Mosquito Control (methods)</term><term>Sex Factors</term><term>Surveys and Questionnaires</term><term>Wuchereria bancrofti</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Albendazole (administration et posologie)</term><term>Albendazole (usage thérapeutique)</term><term>Animaux</term><term>Connaissances, attitudes et pratiques en santé</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Enquêtes et questionnaires</term><term>Facteurs sexuels</term><term>Femelle</term><term>Filaricides (administration et posologie)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (psychologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Insecticides</term><term>Jeune adulte</term><term>Lutte contre les moustiques ()</term><term>Moustiquaires de lit traitées aux insecticides</term><term>Mâle</term><term>Observance du traitement médicamenteux (psychologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Wuchereria bancrofti</term><term>Égypte (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Egypt</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mosquito Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Observance du traitement médicamenteux</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Égypte</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Insecticide-Treated Bednets</term><term>Insecticides</term><term>Male</term><term>Middle Aged</term><term>Sex Factors</term><term>Surveys and Questionnaires</term><term>Wuchereria bancrofti</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Connaissances, attitudes et pratiques en santé</term><term>Enquêtes et questionnaires</term><term>Facteurs sexuels</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Insecticides</term><term>Jeune adulte</term><term>Lutte contre les moustiques</term><term>Moustiquaires de lit traitées aux insecticides</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Égypte</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF) has been targeted for global elimination by 2020. The primary tool for the program is mass drug administration (MDA) with antifilarial medications to reduce the source of microfilariae required for mosquito transmission of the parasite. This strategy requires high MDA compliance rates. Egypt initiated a national filariasis elimination program in 2000 that targeted approximately 2.7 million persons in 181 disease-endemic localities. This study assessed factors associated with MDA compliance in year three of the Egyptian LF elimination program. 2,859 subjects were interviewed in six villages. The surveyed compliance rate for MDA in these villages was 85.3% (95% confidence interval = 83.9-86.5%). Compliance with MDA was positively associated with LF knowledge scores, male sex, and older age. Adverse events reported by 18.4% of participants were mild and more common in females. This study has provided new information on factors associated with MDA compliance during Egypt's successful LF elimination program.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23751402</PMID><DateCreated><Year>2013</Year><Month>08</Month><Day>08</Day></DateCreated><DateCompleted><Year>2013</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The American journal of tropical medicine and hygiene</Title><ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation></Journal><ArticleTitle>Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.</ArticleTitle><Pagination><MedlinePgn>260-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.12-0491</ELocationID><Abstract><AbstractText>Lymphatic filariasis (LF) has been targeted for global elimination by 2020. The primary tool for the program is mass drug administration (MDA) with antifilarial medications to reduce the source of microfilariae required for mosquito transmission of the parasite. This strategy requires high MDA compliance rates. Egypt initiated a national filariasis elimination program in 2000 that targeted approximately 2.7 million persons in 181 disease-endemic localities. This study assessed factors associated with MDA compliance in year three of the Egyptian LF elimination program. 2,859 subjects were interviewed in six villages. The surveyed compliance rate for MDA in these villages was 85.3% (95% confidence interval = 83.9-86.5%). Compliance with MDA was positively associated with LF knowledge scores, male sex, and older age. Adverse events reported by 18.4% of participants were mild and more common in females. This study has provided new information on factors associated with MDA compliance during Egypt's successful LF elimination program.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abd Elaziz</LastName><ForeName>Khaled M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, and Research and Training Center on Vector of Diseases Ain Shams University, Cairo, Egypt. khaledabdu@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Setouhy</LastName><ForeName>Maged</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bradley</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Ramzy</LastName><ForeName>Reda M R</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Weil</LastName><ForeName>Gary J</ForeName><Initials>GJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 AI035855</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI065715</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI-35855</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI-65715</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Trop Med Hyg</MedlineTA><NlmUniqueID>0370507</NlmUniqueID><ISSNLinking>0002-9637</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007306">Insecticides</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2005 Oct;73(4):753-8</RefSource><PMID Version="1">16222021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010;4(6):e728</RefSource><PMID Version="1">20628595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2006 Jun;11(6):862-8</RefSource><PMID Version="1">16772008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:395-441</RefSource><PMID Version="1">16735170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2004 Jun;9(6):702-9</RefSource><PMID Version="1">15189460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2005 Aug 02;4:7</RefSource><PMID Version="1">16076397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2004 Oct;98(7):703-14</RefSource><PMID Version="1">15509424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Public Health. 2004 Mar;118(2):121-7</RefSource><PMID Version="1">15037042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource><PMID Version="1">16564361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2003 Dec;8(12):1082-92</RefSource><PMID Version="1">14641843</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057148" MajorTopicYN="N">Insecticide-Treated Bednets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007306" MajorTopicYN="N">Insecticides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009032" MajorTopicYN="N">Mosquito Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3741246</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23751402</ArticleId><ArticleId IdType="pii">ajtmh.12-0491</ArticleId><ArticleId IdType="doi">10.4269/ajtmh.12-0491</ArticleId><ArticleId IdType="pmc">PMC3741246</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Égypte</li></country></list><tree><noCountry><name sortKey="Bradley, Mark H" sort="Bradley, Mark H" uniqKey="Bradley M" first="Mark H" last="Bradley">Mark H. Bradley</name><name sortKey="El Setouhy, Maged" sort="El Setouhy, Maged" uniqKey="El Setouhy M" first="Maged" last="El-Setouhy">Maged El-Setouhy</name><name sortKey="Ramzy, Reda M R" sort="Ramzy, Reda M R" uniqKey="Ramzy R" first="Reda M R" last="Ramzy">Reda M R. Ramzy</name><name sortKey="Weil, Gary J" sort="Weil, Gary J" uniqKey="Weil G" first="Gary J" last="Weil">Gary J. Weil</name></noCountry><country name="Égypte"><noRegion><name sortKey="Abd Elaziz, Khaled M" sort="Abd Elaziz, Khaled M" uniqKey="Abd Elaziz K" first="Khaled M" last="Abd Elaziz">Khaled M. Abd Elaziz</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001A75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23751402
|texte= Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23751402" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |